SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001297184-23-000082
Filing Date
2023-11-08
Accepted
2023-11-08 16:24:41
Documents
104
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q amph-20230930x10q.htm   iXBRL 10-Q 3139577
2 EX-31.1 amph-20230930xex31d1.htm EX-31.1 19169
3 EX-31.2 amph-20230930xex31d2.htm EX-31.2 18824
4 EX-32.1 amph-20230930xex32d1.htm EX-32.1 9842
5 EX-32.2 amph-20230930xex32d2.htm EX-32.2 9843
  Complete submission text file 0001297184-23-000082.txt   13240329

Data Files

Seq Description Document Type Size
6 EX-101.SCH amph-20230930.xsd EX-101.SCH 76376
7 EX-101.CAL amph-20230930_cal.xml EX-101.CAL 74248
8 EX-101.DEF amph-20230930_def.xml EX-101.DEF 354083
9 EX-101.LAB amph-20230930_lab.xml EX-101.LAB 590278
10 EX-101.PRE amph-20230930_pre.xml EX-101.PRE 545176
98 EXTRACTED XBRL INSTANCE DOCUMENT amph-20230930x10q_htm.xml XML 2751306
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

IRS No.: 330702205 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36509 | Film No.: 231388259
SIC: 2834 Pharmaceutical Preparations